I am a recent investor in EBR (today) and I am confident in the product. I traditionally purchase shares based on where they are in FDA trials. This company is a little different, as the timelines are not as clear. Can anyone direct me as to where the catalysts are for this companies launch of its product particularly into the US market? When would this be expected, and is there literature on this?
Thanks and all the best!
I am a recent investor in EBR (today) and I am confident in the...
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.04 |
Change
0.045(4.52%) |
Mkt cap ! $320.4M | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.04 | $1.00 | $118.6K | 116.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50 | $1.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.04 | 4925 | 1 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.04 |
Change
0.045 ( 3.94 %) |
||||
| Open | High | Low | Volume | ||
| $1.02 | $1.04 | $1.00 | 21538 | ||
| Last updated 15.42pm 17/05/2024 ? | |||||
| EBR (ASX) Chart |